Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan in neonates with transposition of the great arteries
NCT01120106Phase 2Completed
- Start
- Jan 2009
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of levosimendan in low cardiac output syndrome (LCOS). Primary endpoint: Inotropic score at 72 hours. Started Jan 2009; status: completed.
02
Drugs
levosimendan
03
Conditions
low cardiac output syndrome (LCOS)
Beyond the preview
Go deeper on NCT01120106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01120106.